Actively Recruiting
Manual Therapy on Oral Opening, Swallow Function and Upper Quarter Mobility on Head and Neck Cancer Survivors
Led by Universidad de La Frontera · Updated on 2025-05-30
70
Participants Needed
2
Research Sites
53 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Trismus has been reported as the second most common comorbidity in survivors of head and neck cancer (HNC). It is mainly associated with post-radiotherapy subcutaneous fibrosis, muscular atrophy, damage to neurological structures in the neck, or a combination of all, affecting masticatory musculature. In addition to this, the loss of flexibility and strength in the shoulder has also been shown to be related to deficits in the function and quality of life of these patients. The goal of this clinical trial is to determinate the effectiveness and safety of Manual Therapy (MT) on Oral Opening, Swallow Function, as well as the mobility of the upper quarter, the strength of cervical musculature, pain, functionality, and the perception of quality of life in head and neck cancer survivors. Participants will be assigned randomly to the study groups: a) manual therapy program and control motor exercises and b) motor control exercises (usual care). The assessment refers to a baseline form (at the beginning of the study), at 6 weeks and at 6 weeks of patient follow-up.
CONDITIONS
Official Title
Manual Therapy on Oral Opening, Swallow Function and Upper Quarter Mobility on Head and Neck Cancer Survivors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals diagnosed with head and neck cancer
- Age 18 years or older
- Individuals who have had oncological surgery and/or radiotherapy on the head and neck
- Completed cancer treatment between 3 and 36 months prior to joining
- Medical diagnosis of trismus, temporomandibular disorders, or cervical or shoulder dysfunction
- Native Spanish speakers
You will not qualify if you...
- History of previous stroke
- Structural instability or osteoporosis of the cervical spine, spondylosis, or cervical herniated discs
- Active osteoradionecrosis or open wounds such as fistulas or soft tissue necrosis in the treatment area
- Individuals with a tracheostomy
- Presence of metastasis or active cancer
- Those who refuse to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Barbara Burgos Mansilla
Temuco, Cautin, Chile
Actively Recruiting
2
Universidad de La Frontera
Temuco, Cautin, Chile
Actively Recruiting
Research Team
B
Barbara Burgos, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here